Latest market price
7.00
-0.33-4.50%
OLMAQT14Olema Pharmaceuticals, Inc.·NASDAQ
7.00-4.50%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 16, 2026SC 13D/ABeneficial ownership statement (active, amended)
Oct 15, 20268-KCurrent report
Sep 02, 20264Statement of changes in beneficial ownership
Aug 13, 20268-KCurrent report
Aug 13, 20263Initial statement of beneficial ownership
Aug 10, 202610-QQuarterly report
Aug 10, 20268-KCurrent report
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 27, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
May 26, 20268-KCurrent report
May 21, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)